stars 1 stars 2 stars 3

Digi.Bio is revolutionizing the development of therapies with its AI-driven, lab-on-a-chip platform. Designed for high-content, real-time analysis, the technology enables dynamic monitoring of therapy performance at single-cell resolution. With BSL-2 laboratories at Leiden Bio Science Park and its headquarters in Amsterdam, Digi.Bio provides a digital, single-cell representation of therapy responses, offering unprecedented spatial and temporal insights into treatment behavior.

Digi.Bio Questions

Federico Muffatto is the Founder and CEO of Digi.Bio.

4 people are employed at Digi.Bio.

The NAICS codes for Digi.Bio are [54, 54171, 541713, 5417, 541].

The SIC codes for Digi.Bio are [873, 87].

Top Digi.Bio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users